With Tufts CSDD’s analysis showing the ROI of decentralized trials, more than 76% of sponsors seeking to decentralize future trials.
While adding eCOA or eConsent improves efficiency, it often creates issues for sites and patients.
To fully realize Tufts CSDD’s findings, it takes a centralized system that provides a seamless experience to all stakeholders.
Learn how with this free white paper.
